[go: up one dir, main page]

MD4763B1 - Compoziţie farmaceutică - Google Patents

Compoziţie farmaceutică Download PDF

Info

Publication number
MD4763B1
MD4763B1 MDA20180049A MD20180049A MD4763B1 MD 4763 B1 MD4763 B1 MD 4763B1 MD A20180049 A MDA20180049 A MD A20180049A MD 20180049 A MD20180049 A MD 20180049A MD 4763 B1 MD4763 B1 MD 4763B1
Authority
MD
Moldova
Prior art keywords
pharmaceutical composition
levocarnitine
consequences
injections
medicine
Prior art date
Application number
MDA20180049A
Other languages
English (en)
Russian (ru)
Other versions
MD4763C1 (ro
MD20180049A2 (ro
Inventor
Микола Иванович ГУМЕНЮК
Original Assignee
M. T. K. Medical Center Limited Liability Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from UAU201511330U external-priority patent/UA106905U/uk
Priority claimed from UAA201611435A external-priority patent/UA119768C2/uk
Application filed by M. T. K. Medical Center Limited Liability Company filed Critical M. T. K. Medical Center Limited Liability Company
Publication of MD20180049A2 publication Critical patent/MD20180049A2/ro
Publication of MD4763B1 publication Critical patent/MD4763B1/ro
Publication of MD4763C1 publication Critical patent/MD4763C1/ro

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Invenţia se referă la medicină, şi anume la remedii pentru tratamentul bolii ischemice a cordului şi a consecinţelor ei.Compoziţia farmaceutică conţine hidroclorură de arginină, levocarnitină şi apă pentru injecţii.
MDA20180049A 2015-11-17 2016-11-16 Compoziţie farmaceutică MD4763C1 (ro)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
UAU201511330U UA106905U (uk) 2015-11-17 2015-11-17 Фармацевтична композиція
UAA201611435A UA119768C2 (uk) 2016-11-11 2016-11-11 Фармацевтична композиція
PCT/IB2016/056901 WO2017085642A1 (ru) 2015-11-17 2016-11-16 Фармацевтическая композиция

Publications (3)

Publication Number Publication Date
MD20180049A2 MD20180049A2 (ro) 2018-09-30
MD4763B1 true MD4763B1 (ro) 2021-08-31
MD4763C1 MD4763C1 (ro) 2022-03-31

Family

ID=58718454

Family Applications (1)

Application Number Title Priority Date Filing Date
MDA20180049A MD4763C1 (ro) 2015-11-17 2016-11-16 Compoziţie farmaceutică

Country Status (2)

Country Link
MD (1) MD4763C1 (ro)
WO (1) WO2017085642A1 (ro)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA126094C2 (uk) * 2020-07-24 2022-08-10 Тов "Медичний Центр "М.Т.К." Застосування розчину для інфузій для лікування захворювань, пов'язаних із порушеннями мозкового кровообігу
WO2022018705A1 (en) * 2020-07-24 2022-01-27 M.T.K. Medical Center Limited Liability Company A pharmaceutical composition for treating cardiovascular and cerebrovascular disorders,diseases in pregnant women and improving exercise tolerance
WO2022018707A1 (en) * 2020-07-24 2022-01-27 M.T.K. Medical Center Limited Liability Company Infusion solution comprising arginine hydrochloride and levocarnitine for treatment and prevention of diseases in pregnant women and promotion of fetal development during pregnancy

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101336914B (zh) * 2007-07-03 2011-12-28 常州高新技术产业开发区三维工业技术研究所有限公司 一种缩小心肌梗死面积的药物组合物及其应用
CN103948581B (zh) * 2014-02-26 2018-05-08 青岛大学医学院附属医院 左卡尼汀联合l-精氨酸在制备治疗糖尿病视网膜病变神经损伤药物中的应用

Also Published As

Publication number Publication date
MD4763C1 (ro) 2022-03-31
MD20180049A2 (ro) 2018-09-30
WO2017085642A1 (ru) 2017-05-26

Similar Documents

Publication Publication Date Title
JOP20210109A1 (ar) مشتقات اندول مستبدلة احاديا او ثنائيا بصفتها مانعات للتكاثر الفيروسي لحمى الفنك
PH12019501018A1 (en) Pharmaceutical composition, methods for treating and uses thereof
EA201691582A1 (ru) Новые фармацевтические препараты
CL2016001918A1 (es) Heteroaril amidas como inhibidores de agregación de proteína
PH12017500571A1 (en) Mono-or di-substituted indole derivatives as dengue viral replication inhibitors
EA201691481A1 (ru) ИНГИБИТОРЫ C5a ДЛЯ ЛЕЧЕНИЯ ВИРУСНОЙ ПНЕВМОНИИ
PH12018500569A1 (en) Mono- or di-substituted indole derivatives as dengue viral replication inhibitors
MY187068A (en) Indole derivatives as dengue viral replication inhibitors
EA201691918A1 (ru) Фармацевтические составы ингибитора киназ семейства raf, способы их получения и способы их применения
EA201692111A1 (ru) Фармацевтические композиции, содержащие данириксин, для лечения инфекционных заболеваний
MX2017000676A (es) Oritavancina de alta pureza y metodo para producir la misma.
EA201691796A1 (ru) П-замещенные асимметричные мочевины и их применение в медицине
PH12016502233A1 (en) (s)-pirlindole or its pharmaceutically acceptable salts for use in medicine
MD4763B1 (ro) Compoziţie farmaceutică
CR20160353A (es) Inhibidor de proteína de transferencia del éster de colesterilo (cetp) y composiciones farmacéuticas que comprenden el inhibidor para uso en el tratamiento o prevención de enfermedades cardiovasculares
MX2018014129A (es) Composiciones farmaceuticas de oligomero de morfolino fosforodiamidato.
PH12016502236A1 (en) (r)-pirlindole and its pharmaceutically acceptable salts for use in medicine
TR201903234T4 (tr) Parkinson hastalığının tedavisinde kullanılmaya yönelik dopamin içeren farmasötik çözelti.
MX375468B (es) Amidas de acidos grasos para la prevencion y/o tratamiento de la esteatohepatitis.
MY185672A (en) Mono-or di-substituted indole derivatives as dengue viral replication inhibitors
MY197383A (en) Mono- or di-substituted indole derivatives as dengue viral replication inhibitors
MD20150017A2 (ro) Utilizarea preparatului Polibiolin la pacienţii cu ciroză hepatică
LV15072A (lv) Farmaceitiska kompozīcija izmantošanai patoloģiska stāvokļa, kam raksturīga paaugstināta iNOS gēna ekspresija, profilaksei un ārstēšanai
EA201892675A1 (ru) Фармацевтическая композиция, содержащая этеплирсен
BR112017003900A2 (pt) formulações de testosterona e métodos de tratamento com as mesmas

Legal Events

Date Code Title Description
FG4A Patent for invention issued